Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XC8 for Dry Cough in Acute Respiratory Viral Infection
NCT05269329Phase 2Completed
- Sponsor
- Valenta Pharm
- Start
- Apr 2021
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of histamine glutarimide in acute respiratory viral infection (ARVI), acute bronchitis, sponsored by Valenta Pharm. Started Apr 2021; status: completed.
02
Drugs
histamine glutarimide
03
Conditions
acute respiratory viral infection (ARVI)acute bronchitis
Beyond the preview
Go deeper on NCT05269329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05269329.